Guardian Pharmacy Service... (GRDN)
NYSE: GRDN
· Real-Time Price · USD
23.64
-0.25 (-1.05%)
At close: Aug 15, 2025, 3:59 PM
23.62
-0.06%
After-hours: Aug 15, 2025, 05:05 PM EDT
Guardian Pharmacy Services Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Mar 31, 2021 |
Revenue | 1.33B | 1.28B | 1.23B | 1.17B | 1.12B | 1.07B | 1.05B | 989.2M | 937.51M | 893.96M | 848.6M | 805.84M | 783.32M | 755.1M | 736.95M |
Cost of Revenue | 1.07B | 1.03B | 984.04M | 939.06M | 896.1M | 860.46M | 837.88M | 789.14M | 747.66M | 712.49M | 676.78M | 645.46M | 627.91M | 606.58M | 592.58M |
Gross Profit | 260.48M | 253.62M | 244.37M | 231.84M | 223.16M | 212.19M | 208.31M | 200.06M | 189.85M | 181.47M | 171.82M | 160.37M | 155.41M | 148.53M | 144.37M |
Operating Income | -62.27M | -57.85M | -62.92M | -64.15M | 34.13M | 42.42M | 40.95M | 23.76M | 51.6M | 25.03M | 34.37M | 38.42M | 29.49M | 30.45M | 16.83M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -63.73M | -60.47M | -66.48M | -68.14M | 30.51M | 39.1M | 37.72M | 21M | 49.02M | 22.83M | 32.51M | 36.67M | 27.62M | 28.54M | 14.63M |
Net Income | -82.22M | -80.63M | -87.29M | -87.21M | 14.14M | 24.98M | 23.9M | 5.94M | 35.2M | 8.81M | 19.38M | 25.25M | 16.95M | 18.66M | 5.41M |
Selling & General & Admin | 322.75M | 311.47M | 307.29M | 296M | 189.03M | 169.77M | 167.36M | 176.3M | 149.5M | 175.92M | 154.38M | 135.87M | 124.98M | 105.68M | 114.77M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11.24M | -19.48M | -16.93M | -13.91M | 933K | 12.4M | 12.77M |
Operating Expenses | 322.75M | 311.47M | 307.29M | 296M | 189.03M | 169.77M | 167.36M | 176.3M | 138.25M | 156.44M | 137.45M | 121.95M | 125.92M | 118.08M | 127.54M |
Interest Expense | 1.79M | 2.68M | 3.28M | 3.6M | 3.29M | 2.92M | 2.86M | 2.54M | 2.23M | 1.93M | 1.63M | 1.63M | 1.66M | 1.76M | 1.99M |
Selling & Marketing Expenses | 3.5M | 3.5M | 3.5M | n/a | n/a | 37.02M | 73.86M | 107.52M | 139.24M | 140.63M | 127.03M | 122.84M | 111.95M | 105.68M | 114.77M |
Cost & Expenses | 1.39B | 1.34B | 1.29B | 1.24B | 1.09B | 1.03B | 1.01B | 965.44M | 885.91M | 868.93M | 814.23M | 767.42M | 753.83M | 724.66M | 720.12M |
Income Tax Expense | 12.15M | 8.39M | 4.56M | 176K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 62.05M | 62.04M | 61.14M | 61.14M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M |
Shares Outstanding (Diluted) | 63.2M | 62.91M | 61.14M | 61.14M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M |
EPS (Basic) | -1.5 | -1.48 | -1.93 | -1.93 | -0.12 | 0.06 | 0.39 | 0.09 | 0.58 | 0.15 | 0.32 | 0.42 | 0.28 | 0.31 | 0.09 |
EPS (Diluted) | -1.51 | -1.48 | -1.93 | -1.93 | -0.12 | 0.06 | 0.39 | 0.09 | 0.58 | 0.15 | 0.32 | 0.42 | 0.28 | 0.31 | 0.09 |
EBITDA | -46.7M | -42.37M | -48.3M | -50.08M | 47.9M | 60.55M | 58.81M | 41.08M | 68.22M | 41.43M | 49.06M | 53.46M | 44.73M | 44.65M | 32.45M |
EBIT | -74.7M | -57.78M | -63.2M | -64.54M | 33.79M | 42.02M | 40.58M | 23.54M | 51.25M | 24.76M | 34.14M | 38.29M | 29.28M | 30.3M | 16.62M |
Depreciation & Amortization | 15.41M | 15.41M | 14.9M | 14.46M | 14.1M | 18.53M | 18.23M | 17.54M | 16.97M | 16.67M | 14.92M | 15.16M | 15.46M | 14.34M | 15.83M |